Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei

Kaitlyn J Kelly1, Joel M Baumgartner, Andrew M Lowy

  • 1Division of Surgical Oncology, Department of Surgery, University of California San Diego Moores Cancer Center, 3855 Health Sciences Drive #0987, La Jolla, CA, 92093, USA.

Annals of Surgical Oncology
|November 15, 2014
PubMed
Abstract

Insights

Laparoscopic surgery effectively removes mucinous ascites in pseudomyxoma peritonei (PMP) patients, offering significant symptom relief. This minimally invasive approach provides durable palliation with low complication rates.

Area of Science:

  • Surgical Oncology
  • Gastroenterology
  • Minimally Invasive Surgery

Background:

  • Mucinous ascites accumulation in unresectable pseudomyxoma peritonei (PMP) causes significant patient morbidity.
  • Traditional paracentesis is limited by adhesions, disease burden, and ascites viscosity.
  • Laparoscopic evacuation offers a potential palliative solution for PMP-related mucinous ascites.

Purpose of the Study:

  • To review the experience with laparoscopic evacuation of mucinous ascites for PMP palliation.
  • To assess the feasibility, safety, and efficacy of this minimally invasive approach.

Main Methods:

  • Retrospective review of patients undergoing laparoscopy for carcinomatosis (July 2007-January 2014).
  • Identified 10 patients who underwent 17 laparoscopic procedures for palliative mucinous ascites evacuation.
  • Detailed analysis of surgical techniques, complications, outcomes, and follow-up data.

Main Results:

  • All 10 patients had primary appendiceal cancers and symptomatic ascites.
  • Median mucin volume evacuated was 2.0 liters; all procedures were same-day surgeries with no hospitalizations.
  • All patients reported symptomatic improvement; median follow-up was 9.1 months with a median of 5.3 months to symptom recurrence requiring repeat intervention.

Conclusions:

  • Laparoscopic evacuation of mucinous ascites is a feasible option for select PMP patients.
  • The procedure provides significant and durable symptom control.
  • Minimal morbidity is associated with this minimally invasive palliative intervention.

Related Concept Videos